In recognition of #AMLWorldAwarenessDay, the NCRI AML18 trial reports DAGO2 induction is superior to CPX-351 for older patients without adverse-risk cytogenetics. 🩺 With @bloodjournals.hematology.org.
Read the review: https://bit.ly/3OEKzQ7
#AMLsm #KnowAML #Leukemia
Today, on World Acute Myeloid Leukemia(AML) day, we are reflecting on the progress that has been made & the continued importance of research for effective treatment options. Our clinical trial REM-422 in patients with AML or Higher Risk MDS is ongoing. 👉https://bit.ly/4jfuhH9
#KnowAML
A graphic showing 10 figures of people. Two are filled in white and eight are filled in black. The text reads, ‘80% of those diagnosed with AML don’t survive beyond five years'.
Acute myeloid leukaemia (AML) has one of the worst survival rates for any type of cancer. Nearly 80% of those diagnosed with AML don’t survive beyond five years. 💔
This Monday (21st April) marks AML World Awareness Day. Please repost and help us raise awareness. #KnowAML
Every year, more than 3,100 people in the UK are diagnosed with acute myeloid leukaemia (AML). But what is AML? How does it develop and who is it most likely to affect? 🤔
Watch our short film and RT to help us raise awareness. #KnowAML
